Searched for
PHARMACEUTICAL REGULATORY
USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'The facility belongs to Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma. The US Food and Drug Administration (...- Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAFollowing an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Vol...
- Bigger cheques, fewer winners in India’s AI boomIndian AI startups raised $1.6 billion in funding during the first nine months of 2026. While AI infrastructure attracted significant inves...
- Diwali dhamaka isn’t over! How a Rs 38 lakh crore bull run sent Sensex up 8,000 points and Nifty up 10% in 8 daysIndia’s Diwali rally has added nearly Rs 38 lakh crore to BSE-listed companies’ market value in just eight trading sessions, with the Sense...
- Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
- India drawing up list of export snags in South AsiaIndia is identifying regulatory and market-access barriers in seven South Asian countries to expand exports and reach its $1-trillion targe...
- Q2 Earnings Scorecard: Which sectors outperformed and which fell behind?The September quarter results indicate strong revenue and profit growth in sectors like automobiles and banking. In contrast, sectors such ...
- Sebi approves 6 IPOs including Mahanadi Coalfields, Veritas Finance and Sagar Defence. Check detailsSebi has granted approval for initial public offerings from six companies across various sectors. Companies like Mahanadi Coalfields and Sa...
- Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoYGland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. Th...
- Morepen Laboratories launches Desloratadine (Rx) generic drug product in US marketMorepen Laboratories has launched its prescription generic product Desloratadine in the United States market. This launch is managed throug...
- FDA flags persistent data-integrity lapses, insanitary conditions at Indian drug facilitiesThe US FDA continues to identify serious data integrity issues in Indian pharmaceutical manufacturing facilities. During inspections, inspe...
- Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...
- OpenAI to acquire developer tools firm Pierre to expand Codex capabilitiesOpenAI will acquire Pierre Computer Company, the developer of open-source coding tools, to expand its Codex platform's capabilities in buil...
- Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 croreZydus Lifesciences reported a net profit of ₹925.5 crore for the September quarter, which declined by 26.6%. The company's revenue from ope...
- Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brok...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 croreEmcure Pharmaceuticals Ltd has posted a remarkable consolidated net profit of Rs 325.06 crore for the September quarter, reflecting substan...
- Alkem Laboratories appoints Amrut Naik as CEOAlkem Laboratories announced the appointment of Amrut Naik as its new Chief Executive Officer. His appointment is effective from November 1...
- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- India's pharma exports rise 4.9% to USD 16.14 bn in H1; shipments to Europe up nearly 10%: PharmexcilIndia's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driv...
Load More
